Value through Innovation16 January 2013

Cardiovascular Disease News & Information

Cardiovascular Disease (CVD) News and Information

This section includes information and resources about Cardiovascular Disease for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.

Cardiovascular Disease Press Releases

back12 next

14.06.2010	Boehringer Ingelheim affirms safety of telmisartan with an analysis of 50,000 patients and strongly disagrees with the publication of Sipahi et al in Lancet Oncology June 2010 - For Medical Media Only
27.11.2009	Major European regulatory milestone in cardiovascular protection for Micardis® (telmisartan): Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients - For medical media, outside the US only
19.10.2009	FDA approves Micardis® (telmisartan) as the first treatment in its class to reduce the risk of heart attack, stroke, or death from cardiovascular causes in patients at high cardiovascular risk who are unable to take ACE inhibitors - For medical media, outside the US only